Published Wed, 01 Aug 2018 20:18:44 -0400 on Seeking Alpha
Actionable Conclusions (1-10): Brokers Estimated Top Ten High Yield Healthcare "Safer" Dividend Stocks to Net 11.75% to 22.98% Gains To July 2019 Three of ten top 'safer' dividend Healthcare stocks by yield (shaded in the chart above) were verified as being among the top ten gainers for the coming year. Thus, based on analyst 1-year target prices, the dog strategy for this Health group graded out as 30% accurate in July.
Projections based on estimated dividends from $1000 invested in the ten highest yielding Healthcare stocks, and aggregate one-year analyst mean target prices for those stocks, as reported by YCharts, created the 2019 data points. Note: one-year target prices from one analyst were not applied (n/a).Ten probable profit-generating trades to 2019 were:
McKesson (MCK) netted $229.88 based on estimates from eighteen analysts plus dividends, less broker fees. The Beta number showed this estimate subject to volatility 29% more than the market as a whole.
AbbVie (ABBV) netted $209.52 based on a median target price estimate from twenty-three analysts plus dividends, less broker fees. The Beta number showed this estimate subject to volatility 61% more than the market as a whole.
AmerisourceBergen (ABC) netted $200.84 based on estimates from eighteen analysts plus dividends, less broker fees. The Beta number showed this estimate subject to volatility 4% over the market as a whole.
Sanofi (SNY) netted $164.74 based on a median of estimates... Read more
|Stock name||Last trade||P/E||Earnings/Share||Dividend/Share||Dividend yield|
|JOHNSON & JOHNSON||132.50||24.5||5.40||3.80||2.83|
|NOVO NORDISK A/S||47.72||19.4||2.46||1.11||2.34|
|FRESENIUS MEDICAL CARE||39.50||10.5||3.77||0.45||1.14|
Older articles featuring Abbvie (ABBV):Income Investing And The Changing Yield Curve
A Real Dividend Growth Machine: 2019 Mid-Year Portfolio Review
June Dividend Jubilee In The Rose 94 Stock Portfolio With Value Up 14.99% For First Half 2019
Bunker Portfolio: A New Strategy And Our Latest Dividend Aristocrat
The Best Dividend Stocks To Buy During The Rate Cut Rally
My Dividend Growth Portfolio: Q2 2019 Summary
Hunting For The Right Dividend Stock
Dividend Challenger Highlights: Week Of July 7
Kiplinger Calls These July International Aristocrats The Most Reliable Dividend Stocks On Earth
The Most Undervalued And Overvalued Dividend Aristocrats - July 2019